|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
18.54(B) |
Last
Volume: |
676,634 |
Avg
Vol: |
1,177,221 |
52
Week Range: |
$120.62 - $144.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 724 |
Guru Rank Value : 1.3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
16,337 |
16,337 |
16,337 |
534,469 |
Total Sell Value |
$2,062,619 |
$2,062,619 |
$2,062,619 |
$75,079,355 |
Total People Sold |
3 |
3 |
3 |
6 |
Total Sell Transactions |
6 |
6 |
6 |
24 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Samad Samer Abdul |
Executive Vice President & CFO |
|
2023-10-23 |
4 |
A |
$122.86 |
$2,212 |
D/D |
18 |
16,493 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2023-10-23 |
4 |
A |
$122.84 |
$6,387 |
D/D |
52 |
12,492 |
|
- |
|
Gardner Mark A |
SVP of Molecular Gen & Oncol |
|
2023-09-25 |
4 |
D |
$126.22 |
$14,642 |
D/D |
(116) |
2,805 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2023-08-15 |
4 |
D |
$135.23 |
$10,007 |
D/D |
(74) |
11,294 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2023-07-25 |
4 |
A |
$144.59 |
$3,615 |
D/D |
25 |
11,355 |
|
- |
|
Gregg Vicky B |
Director |
|
2023-07-25 |
4 |
A |
$144.59 |
$11,278 |
D/D |
78 |
18,649 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2023-07-25 |
4 |
A |
$144.59 |
$6,362 |
D/D |
44 |
12,397 |
|
- |
|
Samad Samer Abdul |
Executive Vice President & CFO |
|
2023-07-14 |
4 |
D |
$140.18 |
$547,964 |
D/D |
(3,909) |
16,475 |
|
- |
|
Morrison Denise M |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
7,955 |
|
- |
|
Gregg Vicky B |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
18,571 |
|
- |
|
Lassiter Wright Iii |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
6,092 |
|
- |
|
Ring Timothy M |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
25,744 |
|
- |
|
Pfeiffer Gary M |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
26,839 |
|
- |
|
Main Timothy L |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
23,612 |
|
- |
|
Doi Tracey |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
3,621 |
|
- |
|
Diaz Luis |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
1,369 |
|
- |
|
Wilensky Gail R |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,369 |
20,506 |
|
- |
|
Gregg Vicky B |
Director |
|
2023-04-24 |
4 |
A |
$143.08 |
$10,302 |
D/D |
72 |
17,202 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2023-04-24 |
4 |
A |
$143.08 |
$3,577 |
D/D |
25 |
11,295 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2023-04-24 |
4 |
A |
$143.08 |
$6,296 |
D/D |
44 |
12,319 |
|
- |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2023-03-24 |
4 |
D |
$134.25 |
$22,823 |
D/D |
(170) |
3,480 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2023-03-24 |
4 |
D |
$134.25 |
$13,291 |
D/D |
(99) |
12,258 |
|
- |
|
Doherty Catherine T. |
SVP, Regional Businesses |
|
2023-03-07 |
4 |
AS |
$140.55 |
$745,899 |
D/D |
(5,307) |
67,810 |
|
2% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2023-03-07 |
4 |
AS |
$140.55 |
$668,175 |
D/D |
(4,754) |
38,527 |
|
2% |
|
Davis J. E. |
CEO and President |
|
2023-03-06 |
4 |
D |
$147.86 |
$1,188,203 |
D/D |
(8,036) |
102,634 |
|
- |
|
787 Records found
|
|
Page 3 of 32 |
|
|